| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Transcription Factors | 2 | 2018 | 784 | 0.93 | Why? |
| Thinness | 2 | 2018 | 99 | 0.83 | Why? |
| Umbelliferones | 1 | 2019 | 1 | 0.82 | Why? |
| Sulfinic Acids | 1 | 2019 | 13 | 0.79 | Why? |
| alpha-Synuclein | 1 | 2019 | 71 | 0.76 | Why? |
| Tracheal Neoplasms | 1 | 2018 | 16 | 0.75 | Why? |
| Bronchial Neoplasms | 1 | 2018 | 18 | 0.74 | Why? |
| Insulin-Like Growth Factor I | 1 | 2019 | 119 | 0.73 | Why? |
| Wnt Signaling Pathway | 1 | 2017 | 87 | 0.67 | Why? |
| Cadherins | 1 | 2017 | 145 | 0.67 | Why? |
| Small Cell Lung Carcinoma | 1 | 2018 | 133 | 0.63 | Why? |
| Cell Differentiation | 2 | 2019 | 1338 | 0.62 | Why? |
| Models, Genetic | 1 | 2018 | 434 | 0.60 | Why? |
| Physiology | 1 | 2016 | 62 | 0.57 | Why? |
| Epithelial-Mesenchymal Transition | 1 | 2017 | 242 | 0.57 | Why? |
| Neoplasm Metastasis | 1 | 2018 | 682 | 0.57 | Why? |
| RNA, Long Noncoding | 1 | 2017 | 408 | 0.48 | Why? |
| Overweight | 2 | 2018 | 916 | 0.46 | Why? |
| Disseminated Intravascular Coagulation | 1 | 2020 | 994 | 0.45 | Why? |
| Data Interpretation, Statistical | 1 | 2016 | 657 | 0.45 | Why? |
| Lung Neoplasms | 2 | 2017 | 3228 | 0.41 | Why? |
| Parkinson Disease | 2 | 2019 | 1414 | 0.39 | Why? |
| Lung Injury | 1 | 2019 | 919 | 0.39 | Why? |
| Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 896 | 0.36 | Why? |
| Body Mass Index | 2 | 2018 | 4306 | 0.34 | Why? |
| Amyloid beta-Peptides | 1 | 2019 | 185 | 0.34 | Why? |
| Granulomatosis with Polyangiitis | 1 | 2018 | 161 | 0.30 | Why? |
| Liver Diseases | 1 | 2021 | 2698 | 0.29 | Why? |
| Plasmapheresis | 1 | 2018 | 437 | 0.27 | Why? |
| Pneumonia | 2 | 2021 | 5652 | 0.25 | Why? |
| Printing, Three-Dimensional | 1 | 2018 | 624 | 0.23 | Why? |
| Gastrointestinal Hemorrhage | 1 | 2018 | 669 | 0.23 | Why? |
| Students, Medical | 1 | 2021 | 4032 | 0.23 | Why? |
| Pulmonary Disease, Chronic Obstructive | 3 | 2018 | 3832 | 0.22 | Why? |
| Rats | 2 | 2019 | 2764 | 0.22 | Why? |
| Drug Delivery Systems | 2 | 2018 | 1365 | 0.20 | Why? |
| Protein Aggregates | 1 | 2019 | 51 | 0.20 | Why? |
| Farnesyltranstransferase | 1 | 2018 | 8 | 0.20 | Why? |
| Tumor Necrosis Factor-alpha | 2 | 2020 | 2483 | 0.19 | Why? |
| Laryngoscopes | 1 | 2021 | 121 | 0.19 | Why? |
| Myeloid Differentiation Factor 88 | 1 | 2019 | 109 | 0.19 | Why? |
| Alzheimer Disease | 1 | 2019 | 1020 | 0.19 | Why? |
| Toll-Like Receptor 4 | 2 | 2019 | 390 | 0.18 | Why? |
| X Chromosome Inactivation | 1 | 2018 | 23 | 0.18 | Why? |
| Visual Pathways | 1 | 2017 | 21 | 0.18 | Why? |
| Thyroxine-Binding Globulin | 1 | 2017 | 1 | 0.18 | Why? |
| Disulfides | 1 | 2019 | 161 | 0.18 | Why? |
| Nucleotide Motifs | 1 | 2018 | 58 | 0.18 | Why? |
| Ciprofloxacin | 1 | 2019 | 130 | 0.18 | Why? |
| Thrombosis | 1 | 2020 | 7504 | 0.18 | Why? |
| Guanidine | 1 | 2017 | 51 | 0.17 | Why? |
| Synapses | 1 | 2017 | 83 | 0.17 | Why? |
| Sleep Wake Disorders | 1 | 2019 | 1463 | 0.17 | Why? |
| Sequence Analysis, Protein | 1 | 2018 | 309 | 0.17 | Why? |
| Neuronal Plasticity | 1 | 2017 | 98 | 0.17 | Why? |
| Research Design | 4 | 2021 | 5830 | 0.17 | Why? |
| Fatty Acids | 1 | 2018 | 238 | 0.16 | Why? |
| Methylprednisolone | 1 | 2018 | 2107 | 0.16 | Why? |
| Survival Analysis | 2 | 2021 | 7592 | 0.16 | Why? |
| Thienamycins | 1 | 2017 | 72 | 0.16 | Why? |
| Serum Albumin | 1 | 2020 | 571 | 0.16 | Why? |
| Antigens, Neoplasm | 1 | 2018 | 230 | 0.16 | Why? |
| Transfection | 1 | 2019 | 864 | 0.16 | Why? |
| Rats, Sprague-Dawley | 1 | 2019 | 987 | 0.15 | Why? |
| Repressor Proteins | 1 | 2017 | 232 | 0.15 | Why? |
| Hemorrhage | 1 | 2018 | 3013 | 0.15 | Why? |
| Hepatocytes | 1 | 2018 | 549 | 0.14 | Why? |
| Lung | 3 | 2020 | 31049 | 0.14 | Why? |
| Uric Acid | 1 | 2018 | 285 | 0.14 | Why? |
| Carrier Proteins | 1 | 2018 | 513 | 0.14 | Why? |
| Lipopolysaccharides | 1 | 2019 | 848 | 0.14 | Why? |
| Gram-Negative Bacteria | 1 | 2019 | 473 | 0.14 | Why? |
| Lung Diseases | 1 | 2018 | 2361 | 0.13 | Why? |
| Energy Metabolism | 1 | 2018 | 451 | 0.13 | Why? |
| Epitope Mapping | 1 | 2019 | 1240 | 0.13 | Why? |
| Glucose | 1 | 2018 | 573 | 0.13 | Why? |
| Adipose Tissue | 1 | 2019 | 612 | 0.13 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.13 | Why? |
| Interleukin-1beta | 1 | 2019 | 992 | 0.13 | Why? |
| Homeostasis | 1 | 2017 | 582 | 0.13 | Why? |
| Signal Transduction | 3 | 2019 | 7207 | 0.13 | Why? |
| Humans | 39 | 2021 | 930598 | 0.12 | Why? |
| Neoplasm Proteins | 1 | 2018 | 501 | 0.12 | Why? |
| Colon | 1 | 2018 | 669 | 0.12 | Why? |
| Antibodies | 1 | 2019 | 846 | 0.12 | Why? |
| Practice Guidelines as Topic | 4 | 2021 | 15421 | 0.12 | Why? |
| Glucocorticoids | 1 | 2018 | 4431 | 0.12 | Why? |
| Health Priorities | 1 | 2020 | 959 | 0.11 | Why? |
| Gram-Negative Bacterial Infections | 1 | 2017 | 398 | 0.11 | Why? |
| NF-kappa B | 1 | 2019 | 1301 | 0.11 | Why? |
| Sepsis | 2 | 2019 | 3517 | 0.11 | Why? |
| Ferritins | 1 | 2020 | 2055 | 0.11 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2020 | 10649 | 0.11 | Why? |
| A549 Cells | 1 | 2017 | 2066 | 0.11 | Why? |
| Inflammasomes | 1 | 2018 | 710 | 0.11 | Why? |
| Male | 19 | 2021 | 367725 | 0.11 | Why? |
| Anti-Bacterial Agents | 3 | 2017 | 10083 | 0.11 | Why? |
| Methicillin-Resistant Staphylococcus aureus | 1 | 2017 | 711 | 0.11 | Why? |
| Betacoronavirus | 9 | 2020 | 204454 | 0.11 | Why? |
| Cells, Cultured | 2 | 2019 | 5835 | 0.11 | Why? |
| ROC Curve | 2 | 2020 | 6024 | 0.11 | Why? |
| Symptom Assessment | 3 | 2020 | 4967 | 0.11 | Why? |
| Inspiratory Capacity | 1 | 2010 | 47 | 0.11 | Why? |
| Acute Lung Injury | 1 | 2019 | 904 | 0.10 | Why? |
| Severity of Illness Index | 5 | 2020 | 48226 | 0.10 | Why? |
| Female | 17 | 2021 | 380317 | 0.10 | Why? |
| Animals | 7 | 2019 | 78931 | 0.10 | Why? |
| Sputum | 1 | 2018 | 1720 | 0.10 | Why? |
| Escherichia coli | 1 | 2017 | 1547 | 0.10 | Why? |
| Medical Staff, Hospital | 1 | 2020 | 1258 | 0.10 | Why? |
| Thoracic Surgery | 1 | 2017 | 623 | 0.10 | Why? |
| Aged | 14 | 2021 | 215776 | 0.10 | Why? |
| Endoscopy, Gastrointestinal | 1 | 2020 | 1545 | 0.10 | Why? |
| Non-alcoholic Fatty Liver Disease | 1 | 2018 | 907 | 0.09 | Why? |
| Nerve Regeneration | 1 | 2018 | 26 | 0.09 | Why? |
| Bone Regeneration | 1 | 2018 | 35 | 0.09 | Why? |
| Pneumonia, Viral | 10 | 2020 | 243684 | 0.09 | Why? |
| Chloroquine | 2 | 2021 | 3152 | 0.09 | Why? |
| Quality of Life | 1 | 2010 | 9820 | 0.09 | Why? |
| Recombinant Proteins | 1 | 2019 | 3786 | 0.09 | Why? |
| Retrospective Studies | 7 | 2021 | 105322 | 0.09 | Why? |
| Coronavirus Infections | 10 | 2020 | 253789 | 0.09 | Why? |
| Peptide Fragments | 1 | 2019 | 2075 | 0.09 | Why? |
| Prognosis | 3 | 2021 | 32490 | 0.09 | Why? |
| Mice, Inbred BALB C | 1 | 2019 | 5814 | 0.09 | Why? |
| tau Proteins | 1 | 2019 | 162 | 0.09 | Why? |
| Microbiota | 1 | 2018 | 1240 | 0.09 | Why? |
| Noninvasive Ventilation | 1 | 2021 | 2329 | 0.09 | Why? |
| Predictive Value of Tests | 2 | 2020 | 9537 | 0.09 | Why? |
| China | 5 | 2021 | 50654 | 0.09 | Why? |
| Curriculum | 1 | 2021 | 3083 | 0.08 | Why? |
| Guidelines as Topic | 1 | 2020 | 2844 | 0.08 | Why? |
| Antiviral Agents | 4 | 2021 | 41703 | 0.08 | Why? |
| Smoking | 2 | 2018 | 3358 | 0.08 | Why? |
| Respiratory Tract Infections | 2 | 2019 | 6817 | 0.08 | Why? |
| Middle Aged | 13 | 2021 | 270681 | 0.08 | Why? |
| Liver Cirrhosis | 1 | 2018 | 1810 | 0.08 | Why? |
| Tissue Engineering | 1 | 2018 | 190 | 0.08 | Why? |
| Self Report | 1 | 2018 | 3802 | 0.08 | Why? |
| Kidney | 1 | 2020 | 3648 | 0.08 | Why? |
| Protein Domains | 1 | 2019 | 6563 | 0.08 | Why? |
| Adrenal Cortex Hormones | 2 | 2020 | 6537 | 0.07 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.07 | Why? |
| Logistic Models | 1 | 2020 | 9089 | 0.07 | Why? |
| Binding Sites | 1 | 2018 | 6201 | 0.07 | Why? |
| Gene Expression Regulation | 1 | 2018 | 4020 | 0.07 | Why? |
| Community-Acquired Infections | 1 | 2017 | 2328 | 0.07 | Why? |
| Adult | 9 | 2021 | 244371 | 0.07 | Why? |
| Immunotherapy | 1 | 2018 | 2421 | 0.07 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 5993 | 0.07 | Why? |
| Intubation, Intratracheal | 1 | 2020 | 3962 | 0.07 | Why? |
| Liver | 1 | 2018 | 4007 | 0.07 | Why? |
| Models, Molecular | 1 | 2018 | 7616 | 0.07 | Why? |
| Circadian Rhythm | 1 | 2019 | 607 | 0.06 | Why? |
| Respiratory Insufficiency | 2 | 2021 | 7301 | 0.06 | Why? |
| Pulmonary Alveoli | 1 | 2018 | 867 | 0.06 | Why? |
| Respiratory Function Tests | 1 | 2010 | 1755 | 0.06 | Why? |
| Specimen Handling | 1 | 2020 | 6190 | 0.06 | Why? |
| Protein Binding | 1 | 2019 | 11430 | 0.06 | Why? |
| Interleukin-6 | 1 | 2020 | 7522 | 0.06 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.06 | Why? |
| Follow-Up Studies | 1 | 2021 | 17020 | 0.06 | Why? |
| Clinical Trials as Topic | 1 | 2021 | 7330 | 0.06 | Why? |
| gamma-Globulins | 1 | 2020 | 73 | 0.05 | Why? |
| Societies, Medical | 1 | 2017 | 6907 | 0.05 | Why? |
| Administration, Oral | 1 | 2018 | 2340 | 0.05 | Why? |
| Kidney Transplantation | 1 | 2020 | 5397 | 0.05 | Why? |
| Acute Kidney Injury | 1 | 2020 | 5762 | 0.05 | Why? |
| Hydroxychloroquine | 2 | 2021 | 12447 | 0.05 | Why? |
| Risk Factors | 2 | 2021 | 71621 | 0.05 | Why? |
| Pandemics | 14 | 2021 | 389249 | 0.05 | Why? |
| Biomarkers | 2 | 2020 | 23361 | 0.05 | Why? |
| Protein Prenylation | 1 | 2018 | 8 | 0.05 | Why? |
| Models, Biological | 1 | 2017 | 4907 | 0.05 | Why? |
| Mitochondria, Liver | 1 | 2018 | 18 | 0.05 | Why? |
| Microbial Sensitivity Tests | 2 | 2019 | 2886 | 0.05 | Why? |
| Dance Therapy | 1 | 2018 | 13 | 0.05 | Why? |
| Fetal Development | 1 | 2020 | 173 | 0.05 | Why? |
| Retinal Bipolar Cells | 1 | 2017 | 2 | 0.05 | Why? |
| Combined Modality Therapy | 1 | 2018 | 3395 | 0.05 | Why? |
| Retinal Rod Photoreceptor Cells | 1 | 2017 | 4 | 0.05 | Why? |
| Dancing | 1 | 2018 | 40 | 0.05 | Why? |
| Dendrites | 1 | 2017 | 11 | 0.05 | Why? |
| Personal Protective Equipment | 2 | 2020 | 15978 | 0.05 | Why? |
| Cyclization | 1 | 2017 | 46 | 0.05 | Why? |
| HT29 Cells | 1 | 2018 | 108 | 0.05 | Why? |
| Kaplan-Meier Estimate | 2 | 2018 | 4260 | 0.04 | Why? |
| Exercise | 1 | 2018 | 6771 | 0.04 | Why? |
| AMP-Activated Protein Kinases | 1 | 2018 | 93 | 0.04 | Why? |
| Prospective Studies | 3 | 2018 | 43301 | 0.04 | Why? |
| Diet, High-Fat | 1 | 2018 | 161 | 0.04 | Why? |
| Glycolysis | 1 | 2018 | 208 | 0.04 | Why? |
| Axons | 1 | 2017 | 73 | 0.04 | Why? |
| Obesity | 1 | 2018 | 7388 | 0.04 | Why? |
| Cell Count | 1 | 2017 | 228 | 0.04 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.04 | Why? |
| Solubility | 1 | 2018 | 382 | 0.04 | Why? |
| Evidence-Based Medicine | 2 | 2020 | 3228 | 0.04 | Why? |
| Cytokines | 1 | 2019 | 15010 | 0.04 | Why? |
| Dimerization | 1 | 2017 | 475 | 0.04 | Why? |
| Prednisone | 1 | 2020 | 652 | 0.04 | Why? |
| APACHE | 1 | 2018 | 682 | 0.04 | Why? |
| Oxidation-Reduction | 1 | 2018 | 540 | 0.04 | Why? |
| Laryngoscopy | 1 | 2021 | 413 | 0.04 | Why? |
| Phosphatidylinositol 3-Kinases | 1 | 2018 | 347 | 0.04 | Why? |
| Cannula | 1 | 2021 | 750 | 0.04 | Why? |
| Acinetobacter baumannii | 1 | 2019 | 378 | 0.04 | Why? |
| Forced Expiratory Volume | 1 | 2018 | 632 | 0.04 | Why? |
| Proto-Oncogene Proteins c-akt | 1 | 2018 | 372 | 0.04 | Why? |
| Influenza, Human | 1 | 2020 | 10779 | 0.04 | Why? |
| Light | 1 | 2017 | 306 | 0.04 | Why? |
| Proportional Hazards Models | 2 | 2018 | 6543 | 0.04 | Why? |
| Chromatography, High Pressure Liquid | 1 | 2019 | 669 | 0.04 | Why? |
| RNA, Ribosomal, 16S | 1 | 2018 | 793 | 0.04 | Why? |
| RNA Interference | 1 | 2018 | 534 | 0.03 | Why? |
| Caco-2 Cells | 1 | 2018 | 1236 | 0.03 | Why? |
| Pseudomonas aeruginosa | 1 | 2019 | 652 | 0.03 | Why? |
| Escherichia coli Infections | 1 | 2017 | 348 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2020 | 2324 | 0.03 | Why? |
| Mice, Knockout | 1 | 2018 | 1815 | 0.03 | Why? |
| Ribavirin | 1 | 2020 | 1182 | 0.03 | Why? |
| Positive-Pressure Respiration | 1 | 2021 | 1160 | 0.03 | Why? |
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2018 | 581 | 0.03 | Why? |
| Hospitalization | 2 | 2020 | 54280 | 0.03 | Why? |
| Observational Studies as Topic | 1 | 2020 | 1887 | 0.03 | Why? |
| Reproducibility of Results | 2 | 2021 | 11304 | 0.03 | Why? |
| Organ Dysfunction Scores | 1 | 2018 | 1475 | 0.03 | Why? |
| Indoles | 1 | 2020 | 1243 | 0.03 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.03 | Why? |
| Airway Management | 1 | 2021 | 1298 | 0.03 | Why? |
| Linear Models | 1 | 2017 | 1914 | 0.03 | Why? |
| Recovery of Function | 1 | 2021 | 2461 | 0.03 | Why? |
| Multiple Organ Failure | 1 | 2021 | 1724 | 0.03 | Why? |
| Mice, Transgenic | 1 | 2017 | 2739 | 0.03 | Why? |
| Plasma | 1 | 2020 | 1809 | 0.02 | Why? |
| Area Under Curve | 1 | 2017 | 2564 | 0.02 | Why? |
| Exercise Therapy | 1 | 2018 | 976 | 0.02 | Why? |
| Neoplasms | 1 | 2018 | 17251 | 0.02 | Why? |
| Pyrazines | 1 | 2020 | 1783 | 0.02 | Why? |
| Up-Regulation | 1 | 2017 | 2249 | 0.02 | Why? |
| Amides | 1 | 2020 | 1864 | 0.02 | Why? |
| Case-Control Studies | 2 | 2018 | 17671 | 0.02 | Why? |
| Treatment Outcome | 3 | 2021 | 51732 | 0.02 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2017 | 1115 | 0.02 | Why? |
| Staphylococcal Infections | 1 | 2017 | 1099 | 0.02 | Why? |
| Surveys and Questionnaires | 2 | 2018 | 43792 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2018 | 5542 | 0.02 | Why? |
| Oxygen | 1 | 2021 | 3715 | 0.02 | Why? |
| Oxygen Inhalation Therapy | 1 | 2021 | 3629 | 0.02 | Why? |
| Dyspnea | 1 | 2021 | 3847 | 0.02 | Why? |
| Membrane Proteins | 1 | 2018 | 1733 | 0.02 | Why? |
| Gene Expression | 1 | 2018 | 3332 | 0.02 | Why? |
| Health Services Accessibility | 2 | 2020 | 10697 | 0.02 | Why? |
| Family | 1 | 2020 | 2909 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.02 | Why? |
| Proteomics | 1 | 2017 | 2481 | 0.02 | Why? |
| Hospitals, University | 1 | 2018 | 4173 | 0.02 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.02 | Why? |
| Respiratory System | 1 | 2017 | 3213 | 0.02 | Why? |
| Transplant Recipients | 1 | 2020 | 4982 | 0.02 | Why? |
| Survival Rate | 1 | 2018 | 9206 | 0.02 | Why? |
| Immunosuppressive Agents | 1 | 2020 | 6331 | 0.01 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 7868 | 0.01 | Why? |
| Triage | 1 | 2020 | 7151 | 0.01 | Why? |
| Length of Stay | 1 | 2018 | 11042 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2018 | 10998 | 0.01 | Why? |
| Infant, Newborn | 1 | 2020 | 23105 | 0.01 | Why? |
| Mice | 1 | 2017 | 21357 | 0.01 | Why? |
| Infant | 1 | 2020 | 30274 | 0.01 | Why? |
| Child, Preschool | 1 | 2020 | 36283 | 0.01 | Why? |
| Age Factors | 1 | 2017 | 21039 | 0.01 | Why? |
| Incidence | 1 | 2017 | 25622 | 0.01 | Why? |
| Hospital Mortality | 1 | 2018 | 22087 | 0.01 | Why? |
| Time Factors | 1 | 2017 | 31397 | 0.01 | Why? |
| Intensive Care Units | 1 | 2018 | 29594 | 0.01 | Why? |
| Child | 1 | 2020 | 70012 | 0.01 | Why? |
| Adolescent | 1 | 2020 | 86841 | 0.01 | Why? |